Trial Profile
A phase I trial of Herceptin [trastuzumab] and interleukin-12
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Interleukin-12 (Primary) ; Trastuzumab (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 25 Apr 2011 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 05 Mar 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov.
- 23 Mar 2007 New trial record.